Search
for
Sort by
Research 421–450 of 1000+
- TRAIL sensitization of PC3 prostate cancer cells by doxorubicin can be blocked by the anti-oxidant N-acetyl-cysteine or by the iron chelator deferoxamine
- Medikamentöse Therapie des benignen Prostatasyndroms (BPS)
- Doxetaxel: new indication. Prostate cancer: a few more weeks.
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Can we predict prostate size by scoring baldness? The relationship of androgenic alopecia and lower urinary tract symptoms
- A Prospective, 1-Year Trial Using Saw Palmetto Versus Finasteride in the Treatment of Category III Prostatitis/Chronic Pelvic Pain Syndrome
- Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician
- Medical management of benign prostatic hyperplasia
- Analysis of benign prostatic obstruction surgery: A long-term evaluation in a real-life context
- Estudo do estroma reativo prostático após a orquiectomia bilateral e posterior inibição da atividade da aromatase pela crisina e inibição da atividade da 5-alfa-redutase pela finasterida
- MP-03.07: Does finasteride have a preventive effect on a chronic bacterial prostatitis? Pilot study using an animal model
- Androgen biosynthetic pathways in the human prostate
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- New Methods of Endocrine Management of Prostatic Cancer
- Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis
- Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use
- Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase
- Estimating the Contribution of the Prostate to Blood Dihydrotestosterone
- Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer
- Beeinflussen Medikamente gegen das benigne Prostatasyndrom Stimmung oder Kognition?
- Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents.
- Evaluation of Sex Hormone Levels in Benign Prostatic Hyperplasia Patients Treated with 5 Alpha-Reductase Inhibitor (Finasteride) in Amara city/Iraq
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- Androgen receptor-mediated gene activation in prostate cancer cells
- Association between Androgenic Hair Patterns and Prostate Cancer Risk in South Indian Men: A Case-control Study from the Cauvery Delta.
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- Topical Application of Thermobalancing Therapy Enabled by Therapeutic Device Treats Enlarged Prostate and Improves Men's Quality of Life; New Opportunity in BPH Treatment